Researchers awarded up to £1 million to develop gene therapy for serious immunodeficiency

24 Apr 2017, 11:35 a.m.

Bobby Gaspar and Adrian Thrasher in ICH lobby

The UCL Technology Fund (UCLTF) has approved an investment of up to £1 million to support researchers Professor Adrian Thrasher, Professor Bobby Gaspar, and Dr GiorgiaSantilli in developing a gene therapy approach for treating p47phox-deficient chronic granulomatous disease (p47-CGD).

p47-CGD is a rare genetic disorder in which the immune system is compromised. Patients with p47-CGD suffer from serious recurrent infections, as well as widespread tissue inflammation.

The gene therapy approach, which was developed by Professor Thrasher and colleagues funded by the NIHR Great Ormond Street Biomedical Research Centre, could potentially restore the immune system in children with the condition. The funding provided by the UCLTF will support completion of final pre-clinical steps and take the therapy to a first-in-child, proof-of-concept clinical trial. Results from pre-clinical studies and from clinical trials in the US and Europe appear promising.

New plan announced to get more children access to gene therapy treatments

Great Ormond Street Hospital (GOSH) has announced plans to revolutionise how children living with a rare disease can gain access to life-changing treatments.

Patients, families, clinicians and researchers learn together on rare blinding condition

Last December, the Norrie Disease conference took place at University College London, Great Ormond Street Institute of Child Health, organised by the Norrie Disease Foundation and Professor Jane Sowden’s research group.

GOSH patient receives world-first treatment for her 'incurable' T-cell leukaemia

In May 2022, Alyssa, 13 from Leicester, became the first reported patient in the world to receive base-edited T-cells at Great Ormond Street Hospital for Children (GOSH), in collaboration with the UCL Great Ormond Street Institute of Child Health (UCL GOS

Celebrating three years of progress and breakthroughs at the ZCR

We're celebrating three years of the Zayed Centre for Research. That's another year of breakthrough research, with hundreds of clinicians and researchers collaborating to help seriously ill children from across the globe.